Arxis $1.3 billion IPO
We advised Arxis on its IPO
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Revolution Medicines $2.2 billion common stock and convertible notes offerings
We advised the underwriters on the concurrent offerings
General Mills €1.7 billion junior subordinated notes offering
We advised the underwriters on the notes offering
Adagene $70 million registered direct offering
We advised Adagene on the offering
CoreWeave $4 billion convertible senior notes offering
We advised CoreWeave on the offering
Deutsche Bank $1 billion notes offering
We advised the sole bookrunner, joint lead managers and co-managers on the offering
Diamondback Energy $777 million cash tender offers
We advised the dealer managers on the tender offers
Marvell Technology $1 billion senior notes offering
We advised the underwriters on the offering
Cencosud $500 million senior notes offering and concurrent tender offer
We advised the representatives of the initial purchasers and dealer managers on the concurrent offerings
Morgan Stanley SEC-registered financing and structured product programs
We advised Morgan Stanley on the recommencement of these programs